Duyuru • Apr 21
Core Molding Technologies, Inc. to Report Q1, 2026 Results on May 07, 2026 Core Molding Technologies, Inc. announced that they will report Q1, 2026 results at 9:30 AM, US Eastern Standard Time on May 07, 2026 Duyuru • Apr 07
Core Molding Technologies, Inc., Annual General Meeting, May 14, 2026 Core Molding Technologies, Inc., Annual General Meeting, May 14, 2026. Location: 800 manor park drive, columbus, ohio, United States Duyuru • Mar 12
Core Molding Technologies, Inc. (NYSEAM:CMT) announces an Equity Buyback for $7.5 million worth of its shares. Core Molding Technologies, Inc. (NYSEAM:CMT) announces a share repurchase program. Under the program, the company will repurchase up to $7.5 million worth of its shares. Reported Earnings • Mar 11
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: US$1.31 (down from US$1.53 in FY 2024). Revenue: US$273.8m (down 9.5% from FY 2024). Net income: US$11.2m (down 16% from FY 2024). Profit margin: 4.1% (down from 4.4% in FY 2024). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Duyuru • Feb 12
Core Molding Technologies, Inc. to Report Q4, 2025 Results on Mar 10, 2026 Core Molding Technologies, Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 10, 2026 Major Estimate Revision • Nov 11
Consensus EPS estimates fall by 15% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from US$271.0m to US$265.6m. EPS estimate also fell from US$1.37 per share to US$1.16 per share. Net income forecast to grow 67% next year vs 34% growth forecast for Chemicals industry in the US. Consensus price target of US$22.00 unchanged from last update. Share price rose 2.9% to US$18.85 over the past week. Duyuru • Nov 05
Core Molding Technologies, Inc. Provides Earnings Guidance for the Year 2025 Core Molding Technologies, Inc. provided earnings guidance for the year 2025. For the year, the company expects sales to be down 10% to 12% year over year. Reported Earnings • Nov 04
Third quarter 2025 earnings: EPS and revenues miss analyst expectations Third quarter 2025 results: EPS: US$0.22 (down from US$0.36 in 3Q 2024). Revenue: US$58.4m (down 20% from 3Q 2024). Net income: US$1.88m (down 41% from 3Q 2024). Profit margin: 3.2% (down from 4.3% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 45%. Revenue is forecast to grow 6.4% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Duyuru • Oct 16
Core Molding Technologies, Inc. to Report Q3, 2025 Results on Nov 04, 2025 Core Molding Technologies, Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025 Buy Or Sell Opportunity • Oct 01
Now 21% undervalued Over the last 90 days, the stock has risen 15% to US$19.94. The fair value is estimated to be US$25.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.4% over the last 3 years. Earnings per share has grown by 7.2%. Revenue is forecast to grow by 1.2% in a year. Earnings are forecast to grow by 43% in the next year. Recent Insider Transactions Derivative • Sep 19
President notifies of intention to sell stock David Duvall intends to sell 10k shares in the next 90 days after lodging an Intent To Sell Form on the 12th of September. If the sale is conducted around the recent share price of US$21.08, it would amount to US$211k. For the year to December 2018, David's total compensation was 38% salary and 62% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since December 2024, David's direct individual holding has decreased from 238.84k shares to 148.78k. Company insiders have collectively sold US$3.2m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Sep 12
President recently sold US$1.0m worth of stock On the 9th of September, David Duvall sold around 50k shares on-market at roughly US$20.32 per share. This transaction amounted to 25% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by US$3.5m. Recent Insider Transactions Derivative • Sep 10
Independent Director notifies of intention to sell stock Matthew Jauchius intends to sell 6k shares in the next 90 days after lodging an Intent To Sell Form on the 8th of September. If the sale is conducted around the recent share price of US$19.84, it would amount to US$119k. Since March 2025, Matthew has owned 57.54k shares directly. Company insiders have collectively sold US$3.2m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Aug 28
Independent Chairman recently sold US$188k worth of stock On the 26th of August, Thomas Cellitti sold around 10k shares on-market at roughly US$18.81 per share. This transaction amounted to 9.4% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$325k. This was Thomas' only on-market trade for the last 12 months. Recent Insider Transactions Derivative • Aug 26
Independent Chairman notifies of intention to sell stock Thomas Cellitti intends to sell 10k shares in the next 90 days after lodging an Intent To Sell Form on the 25th of August. If the sale is conducted around the recent share price of US$19.47, it would amount to US$195k. Since March 2025, Thomas has owned 106.17k shares directly. Company insiders have collectively sold US$3.1m more than they bought, via options and on-market transactions in the last 12 months. New Risk • Aug 05
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.4% Last year net profit margin: 5.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (3.4% net profit margin). Significant insider selling over the past 3 months (US$810k sold). Duyuru • Jul 17
Core Molding Technologies, Inc. to Report Q2, 2025 Results on Aug 05, 2025 Core Molding Technologies, Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 05, 2025 Recent Insider Transactions • Jun 22
President recently sold US$156k worth of stock On the 18th of June, David Duvall sold around 9k shares on-market at roughly US$16.55 per share. This transaction amounted to 4.4% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$325k. David has been a net seller over the last 12 months, reducing personal holdings by US$3.3m. New Risk • Jun 08
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: US$325k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. This is currently the only risk that has been identified for the company. Recent Insider Transactions • Jun 08
President recently sold US$325k worth of stock On the 5th of June, David Duvall sold around 20k shares on-market at roughly US$16.02 per share. This transaction amounted to 8.2% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by US$2.9m. Major Estimate Revision • May 15
Consensus EPS estimates fall by 12% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from US$302.6m to US$291.3m. EPS estimate also fell from US$1.72 per share to US$1.51 per share. Net income forecast to grow 17% next year vs 26% growth forecast for Chemicals industry in the US. Consensus price target of US$22.00 unchanged from last update. Share price rose 5.0% to US$15.66 over the past week. Reported Earnings • May 09
First quarter 2025 earnings: EPS and revenues miss analyst expectations First quarter 2025 results: EPS: US$0.25 (down from US$0.43 in 1Q 2024). Revenue: US$61.4m (down 21% from 1Q 2024). Net income: US$2.18m (down 42% from 1Q 2024). Profit margin: 3.6% (down from 4.8% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 10%. Earnings per share (EPS) also missed analyst estimates by 24%. Revenue is forecast to grow 1.7% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Duyuru • Apr 29
Core Molding Technologies, Inc. to Report Q1, 2025 Results on May 08, 2025 Core Molding Technologies, Inc. announced that they will report Q1, 2025 results Pre-Market on May 08, 2025 Duyuru • Apr 07
Core Molding Technologies, Inc., Annual General Meeting, May 15, 2025 Core Molding Technologies, Inc., Annual General Meeting, May 15, 2025. Location: 800 manor park drive columbus, ohio, United States Price Target Changed • Mar 12
Price target decreased by 8.3% to US$22.00 Down from US$24.00, the current price target is provided by 1 analyst. New target price is 62% above last closing price of US$13.55. Stock is down 29% over the past year. The company is forecast to post earnings per share of US$1.72 for next year compared to US$1.53 last year. Duyuru • Mar 12
Core Molding Technologies, Inc. Provides Sales Guidance for the Full Year 2025 Core Molding Technologies, Inc. provided sales guidance for the full year 2025. For the period, the company announced most of their 2024 new wins will positively impact revenues in 2025, with full production cycles expected in 2026. They also project the truck cycle upturn starting in the second half of 2025, which continues throughout 2026 due to the new regulation changes in 2027. Despite areas of sales growth in 2025, they expect the full year sales to be flat based on the phase-out of approximately $30 million of Volvo programs, offset by higher tooling revenues and new program revenues resulting from new business wins in 2024. Without this Volvo transition, they would have anticipated Core’s sales up about 10% for the year. This demonstrates the early success of their Invest For Growth strategy, which they kicked off in 2024. Reported Earnings • Mar 11
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: EPS: US$1.53 (down from US$2.37 in FY 2023). Revenue: US$302.4m (down 16% from FY 2023). Net income: US$13.3m (down 34% from FY 2023). Profit margin: 4.4% (down from 5.7% in FY 2023). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) missed analyst estimates by 7.9%. Revenue is forecast to stay flat during the next 2 years compared to a 4.3% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Duyuru • Feb 13
Core Molding Technologies, Inc. to Report Q4, 2024 Results on Mar 11, 2025 Core Molding Technologies, Inc. announced that they will report Q4, 2024 results Pre-Market on Mar 11, 2025 Recent Insider Transactions • Dec 24
President recently sold US$257k worth of stock On the 20th of December, David Duvall sold around 16k shares on-market at roughly US$16.17 per share. This transaction amounted to 5.8% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$350k. David has been a net seller over the last 12 months, reducing personal holdings by US$2.7m. Recent Insider Transactions • Dec 11
President recently sold US$229k worth of stock On the 10th of December, David Duvall sold around 14k shares on-market at roughly US$16.40 per share. This transaction amounted to 4.9% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth US$912k. David has been a net seller over the last 12 months, reducing personal holdings by US$2.4m. Recent Insider Transactions Derivative • Dec 08
President notifies of intention to sell stock David Duvall intends to sell 50k shares in the next 90 days after lodging an Intent To Sell Form on the 6th of December. If the sale is conducted around the recent share price of US$16.58, it would amount to US$829k. For the year to December 2018, David's total compensation was 31% salary and 69% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, David's direct individual holding has decreased from 433.72k shares to 287.38k. Company insiders have collectively sold US$4.7m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Nov 29
Executive VP recently sold US$350k worth of stock On the 26th of November, John Zimmer sold around 20k shares on-market at roughly US$17.75 per share. This transaction amounted to 17% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$912k. John has been a net seller over the last 12 months, reducing personal holdings by US$1.5m. Recent Insider Transactions Derivative • Nov 26
Executive VP notifies of intention to sell stock John Zimmer intends to sell 30k shares in the next 90 days after lodging an Intent To Sell Form on the 25th of November. If the sale is conducted around the recent share price of US$17.83, it would amount to US$535k. Since March 2024, John's direct individual holding has decreased from 185.12k shares to 115.56k. Company insiders have collectively sold US$4.3m more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Nov 14
Core Molding Technologies, Inc. Announces Chief Financial Officer Changes Core Molding Technologies, Inc. announced the planned transition and departure of John Zimmer, Chief Financial Officer, effective May 31, 2025. Mr. Zimmer’s CFO role will transition to Alex J. Panda, effective June 1, 2025. The timing of Mr. Zimmer’s departure will provide the Company with an orderly transition of leadership. Mr. Zimmer will continue to serve in an advisory capacity to ensure a smooth transition and to continue to evaluate potential acquisitions for the Company. Mr. Alex J. Panda joined the Company on October 1, 2014, as Financial Reporting Manager and has since held several key leadership positions within the Accounting and Finance department, including Vice President, Corporate Controller and Operations Controller. Alex played a pivotal role in the Company’s successful turnaround in 2019 and 2020, contributing significantly to operational performance analysis and the refinancing of the Company’s credit facilities. During Alex’s tenure with Core, he helped complete two acquisitions, working through integrations, and ensuring smooth transitions. He also oversaw the development and implementation of the Company’s international tax strategy and compliance. Before joining the Company, Alex worked as an assurance professional at KPMG LLP, where he served large public manufacturing clients, including Motorola Solutions, Inc. and Commercial Vehicle Group, Inc. He holds a bachelor’s degree in business administration from Ohio State University and is a Certified Public Accountant (inactive) in Illinois. Reported Earnings • Nov 05
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Third quarter 2024 results: EPS: US$0.36 (down from US$0.51 in 3Q 2023). Revenue: US$73.0m (down 16% from 3Q 2023). Net income: US$3.16m (down 27% from 3Q 2023). Profit margin: 4.3% (down from 5.0% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 57%. Revenue is forecast to grow 4.9% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Duyuru • Oct 29
Core Molding Technologies Appoints Alex Bantz as Chief Commercial Officer to Lead Strategic Expansion Core Molding Technologies, Inc. announced that Mr. Alex Bantz has been appointed to the position of Chief Commercial Officer, effective immediately. Mr. Alex Bantz joins Core with over 25 years of sales and operational experience through advancing leadership roles. Mr. Bantz served most recently as Vice President of Sales and Marketing for Milsco Manufacturing from 2018 through 2024 and as Business Unit Director from 2014 through 2018. From 2007 through 2014, Mr. Bantz worked for Veyance Technologies and progressed into leadership positions most recently Project Manager of the SIOP Integration and Director of Sales and Marketing for the Global Vibration Control and Hose. Prior to these roles, Bantz worked as Account Executive and Channel Manager for The Goodyear Tire and Rubber Company between 2005 and 2007 and worked for Hendrickson as an engineer, buyer and commodity manager from 1998 to 2005. Mr. Bantz earned his Bachelor of Science in Mechanical Engineering from Ohio State University. Duyuru • Oct 15
Core Molding Technologies, Inc. to Report Q3, 2024 Results on Nov 05, 2024 Core Molding Technologies, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 05, 2024 Recent Insider Transactions • Sep 17
President recently sold US$912k worth of stock On the 13th of September, David Duvall sold around 51k shares on-market at roughly US$17.93 per share. This transaction amounted to 15% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by US$2.6m. Recent Insider Transactions Derivative • Sep 06
President notifies of intention to sell stock David Duvall intends to sell 50k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of September. If the sale is conducted around the recent share price of US$17.45, it would amount to US$872k. For the year to December 2018, David's total compensation was 31% salary and 69% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since September 2023, David's direct individual holding has decreased from 412.65k shares to 338.23k. Company insiders have collectively sold US$6.0m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Aug 20
Insider recently sold US$451k worth of stock On the 19th of August, Renee Anderson sold around 25k shares on-market at roughly US$18.04 per share. This transaction amounted to 32% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$4.9m more than they bought in the last 12 months. Recent Insider Transactions Derivative • Aug 16
Insider notifies of intention to sell stock Renee Anderson intends to sell 25k shares in the next 90 days after lodging an Intent To Sell Form on the 14th of August. If the sale is conducted around the recent share price of US$17.84, it would amount to US$446k. Since September 2023, Renee's direct individual holding has decreased from 85.64k shares to 77.80k. Company insiders have collectively sold US$4.3m more than they bought, via options and on-market transactions in the last 12 months. Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to US$18.09, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in the US. Total returns to shareholders of 23% over the past three years. Reported Earnings • Aug 07
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Second quarter 2024 results: EPS: US$0.74 (down from US$0.93 in 2Q 2023). Revenue: US$88.7m (down 9.2% from 2Q 2023). Net income: US$6.42m (down 19% from 2Q 2023). Profit margin: 7.2% (down from 8.1% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 13%. Earnings per share (EPS) also surpassed analyst estimates by 74%. Revenue is forecast to grow 1.3% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. New Risk • Aug 07
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 4.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 4.4% per year for the foreseeable future. Minor Risk Significant insider selling over the past 3 months (US$1.0m sold). Duyuru • Jul 17
Core Molding Technologies, Inc. to Report Q2, 2024 Results on Aug 06, 2024 Core Molding Technologies, Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 06, 2024 Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to US$17.98, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 17x in the Chemicals industry in the US. Total returns to shareholders of 25% over the past three years. Duyuru • Jul 03
Core Molding Technologies, Inc.(NYSEAM:CMT) dropped from Russell Small Cap Comp Growth Index Core Molding Technologies, Inc.(NYSEAM:CMT) dropped from Russell Small Cap Comp Growth Index Board Change • Jul 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. Independent Director Salvador Miñarro Villalobos was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Jun 21
Independent Director recently sold US$108k worth of stock On the 18th of June, Matthew Jauchius sold around 7k shares on-market at roughly US$16.60 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$398k. Insiders have been net sellers, collectively disposing of US$5.4m more than they bought in the last 12 months. Recent Insider Transactions Derivative • Jun 20
Independent Director notifies of intention to sell stock Matthew Jauchius intends to sell 7k shares in the next 90 days after lodging an Intent To Sell Form on the 18th of June. If the sale is conducted around the recent share price of US$16.30, it would amount to US$106k. Since June 2023, Matthew's direct individual holding has increased from 52.77k shares to 57.29k. Company insiders have collectively sold US$4.3m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Jun 02
Executive VP recently sold US$130k worth of stock On the 28th of May, John Zimmer sold around 7k shares on-market at roughly US$19.69 per share. This transaction amounted to 4.0% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$398k. John has been a net seller over the last 12 months, reducing personal holdings by US$1.7m. Recent Insider Transactions • May 16
President recently sold US$398k worth of stock On the 14th of May, David Duvall sold around 20k shares on-market at roughly US$20.19 per share. This transaction amounted to 4.8% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by US$1.3m. Recent Insider Transactions Derivative • May 15
President notifies of intention to sell stock David Duvall intends to sell 50k shares in the next 90 days after lodging an Intent To Sell Form on the 13th of May. If the sale is conducted around the recent share price of US$20.64, it would amount to US$1.0m. For the year to December 2018, David's total compensation was 31% salary and 69% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since June 2023, David's direct individual holding has decreased from 439.28k shares to 433.72k. Company insiders have collectively sold US$3.8m more than they bought, via options and on-market transactions in the last 12 months. New Risk • May 09
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company. Duyuru • May 09
Core Molding Technologies, Inc. Announces Sales Guidance for the Full Year 2024 Core Molding Technologies, Inc. announced that the company signaled double-digit sales declines for 2024 compared to 2023, and expect the first half of 2024 declines to be higher than second half 2024 declines. First quarter aligned with expectations due to tougher comparisons from channel de-stocking and demand shifts in end markets. The company anticipates second quarter 2024 demand levels to be similar to first quarter 2024 demand levels. The company still anticipate a full year sales decrease of 10% to 15%, consistent with previous guidance. Reported Earnings • May 08
First quarter 2024 earnings: EPS exceeds analyst expectations First quarter 2024 results: EPS: US$0.43 (down from US$0.69 in 1Q 2023). Revenue: US$78.1m (down 22% from 1Q 2023). Net income: US$3.76m (down 35% from 1Q 2023). Profit margin: 4.8% (down from 5.8% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 56%. Revenue is forecast to grow 3.3% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Duyuru • Apr 20
Core Molding Technologies, Inc. to Report Q1, 2024 Results on May 07, 2024 Core Molding Technologies, Inc. announced that they will report Q1, 2024 results Pre-Market on May 07, 2024 Duyuru • Apr 12
Core Molding Technologies, Inc., Annual General Meeting, May 16, 2024 Core Molding Technologies, Inc., Annual General Meeting, May 16, 2024, at 09:00 US Eastern Standard Time. Location: 800 Manor Park Drive, Columbus, OH Columbus United States Agenda: To elect directors; to hold a non-binding advisory vote on the compensation of our named executive officers; to approve an amendment to the core molding technologies, inc. 2021 long-term equity incentive plan; to approve an amendment and restatement of the company’s certificate of incorporation to permit the exculpation of officers; to ratify the appointment of crowe llp as the independent registered public accounting firm for the company for the year ending December 31, 2024; and to consider other matters. Reported Earnings • Mar 13
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: US$2.37 (up from US$1.44 in FY 2022). Revenue: US$357.7m (down 5.2% from FY 2022). Net income: US$20.3m (up 69% from FY 2022). Profit margin: 5.7% (up from 3.2% in FY 2022). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 6.7%. Revenue is forecast to stay flat during the next 2 years compared to a 4.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Duyuru • Mar 12
Core Molding Technologies, Inc. (NYSEAM:CMT) announces an Equity Buyback for $7.5 million worth of its shares. Core Molding Technologies, Inc. (NYSEAM:CMT) announces a share repurchase program. Under the program, the company will repurchase up to $7.5 million worth of its shares. Duyuru • Feb 16
Core Molding Technologies, Inc. to Report Q4, 2023 Results on Mar 12, 2024 Core Molding Technologies, Inc. announced that they will report Q4, 2023 results Pre-Market on Mar 12, 2024 Price Target Changed • Nov 09
Price target decreased by 11% to US$25.00 Down from US$28.00, the current price target is provided by 1 analyst. New target price is 46% above last closing price of US$17.18. Stock is up 57% over the past year. The company is forecast to post earnings per share of US$2.20 for next year compared to US$1.44 last year. Reported Earnings • Nov 08
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: EPS: US$0.50 (up from US$0.15 in 3Q 2022). Revenue: US$86.7m (down 15% from 3Q 2022). Net income: US$4.35m (up 233% from 3Q 2022). Profit margin: 5.0% (up from 1.3% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 8.3%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to stay flat during the next 2 years compared to a 3.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. New Risk • Nov 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 4.1% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$4.2m sold). Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment deteriorates as stock falls 32% After last week's 32% share price decline to US$17.48, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry in the US. Total returns to shareholders of 78% over the past three years. Duyuru • Nov 03
Core Molding Technologies, Inc. Appoints Salvador Miñarro to Its Board of Directors Core Molding Technologies, Inc. announced that Salvador Miñarro has been appointed to its Board of Directors. Mr. Miñarro is the Chief Executive Officer of Darnel Group, a global leader in the production of high-quality, food-grade sustainable packaging solutions and a pioneer in post-consumer recycled material. Prior to the Darnel Group Mr. Miñarro was the President and Chief Executive Officer of Vitro Automotive and also held executive positions in operations, sales and finance at Libbey, Inc. Mr. Miñarro has an executive MBA from Instituto Panamericano de Alta Dirección de Empresas, a Master’s degree in Finance from University of Southern California, and a Bachelor’s degree in Industrial Engineer from Inst. Tecnológico y de Estudios Superiores de Monterrey. Duyuru • Oct 13
Core Molding Technologies, Inc. to Report Q3, 2023 Results on Nov 07, 2023 Core Molding Technologies, Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 07, 2023 Board Change • Oct 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Sandy Kowaleski was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions Derivative • Sep 24
Executive VP notifies of intention to sell stock John Zimmer intends to sell 10k shares in the next 90 days after lodging an Intent To Sell Form on the 22nd of September. If the sale is conducted around the recent share price of US$26.65, it would amount to US$267k. Since March 2023, John's direct individual holding has decreased from 226.78k shares to 198.35k. Company insiders have collectively sold US$2.9m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Sep 07
Executive VP notifies of intention to sell stock John Zimmer intends to sell 30k shares in the next 90 days after lodging an Intent To Sell Form on the 5th of September. If the sale is conducted around the recent share price of US$27.37, it would amount to US$821k. Since March 2023, John's direct individual holding has decreased from 226.78k shares to 224.89k. Company insiders have collectively sold US$1.3m more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Sep 07
Core Molding Technologies, Inc. Announces the Passing of James F. Crowley, Board Member Core Molding Technologies, Inc. announced the passing of James F. Crowley, a member of company's Board of Directors. James Crowley passed away peacefully on August 24, 2023, leaving behind a legacy of leadership and dedication that will forever be remembered. Jim joined the Company’s Board of Directors in 1998 and made significant contributions to organization throughout his tenure. Jim’s wisdom, guidance, and unwavering commitment to Company's mission were instrumental in shaping Company's path to success. Recent Insider Transactions • Aug 29
Insider recently sold US$271k worth of stock On the 24th of August, Renee Anderson sold around 10k shares on-market at roughly US$27.07 per share. This transaction amounted to 8.3% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$402k. Insiders have been net sellers, collectively disposing of US$2.5m more than they bought in the last 12 months. Recent Insider Transactions Derivative • Aug 27
Insider notifies of intention to sell stock Renee Anderson intends to sell 10k shares in the next 90 days after lodging an Intent To Sell Form on the 24th of August. If the sale is conducted around the recent share price of US$27.00, it would amount to US$270k. Since March 2023, Renee's direct individual holding has decreased from 123.35k shares to 120.60k. Company insiders have collectively sold US$1.0m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Aug 15
Executive Vice President of Operations recently sold US$197k worth of stock On the 14th of August, Eric Palomaki sold around 7k shares on-market at roughly US$27.08 per share. This transaction amounted to 5.2% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$371k. This was Eric's only on-market trade for the last 12 months. Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to US$26.75, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Chemicals industry in the US. Total returns to shareholders of 337% over the past three years. Recent Insider Transactions Derivative • Aug 13
Independent Chairman notifies of intention to sell stock Thomas Cellitti intends to sell 15k shares in the next 90 days after lodging an Intent To Sell Form on the 11th of August. If the sale is conducted around the recent share price of US$26.25, it would amount to US$394k. Since March 2023, Thomas' direct individual holding has decreased from 124.19k shares to 105.94k. Company insiders have collectively sold US$1.0m more than they bought, via options and on-market transactions in the last 12 months. New Risk • Aug 11
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 4.1% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 4.1% per year for the foreseeable future. Minor Risks Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$1.3m sold). New Risk • Aug 09
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 4.1% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 4.1% per year for the foreseeable future. Minor Risks Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$1.3m sold). Reported Earnings • Aug 09
Second quarter 2023 earnings: EPS exceeds analyst expectations Second quarter 2023 results: EPS: US$0.93 (up from US$0.26 in 2Q 2022). Revenue: US$97.7m (down 1.0% from 2Q 2022). Net income: US$7.94m (up 270% from 2Q 2022). Profit margin: 8.1% (up from 2.2% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 117%. Revenue is forecast to grow 1.1% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 60% per year. Duyuru • Jul 23
Core Molding Technologies, Inc. to Report Q2, 2023 Results on Aug 08, 2023 Core Molding Technologies, Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 08, 2023 Recent Insider Transactions Derivative • Jul 02
Independent Director notifies of intention to sell stock Matthew Jauchius intends to sell 14k shares in the next 90 days after lodging an Intent To Sell Form on the 29th of June. If the sale is conducted around the recent share price of US$20.00, it would amount to US$285k. Since March 2023, Matthew's direct individual holding has increased from 66.83k shares to 67.03k. Company insiders have collectively sold US$695k more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions • Jun 28
Executive VP recently bought US$51k worth of stock On the 27th of June, John Zimmer bought around 3k shares on-market at roughly US$20.42 per share. This transaction amounted to 1.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. John has been a buyer over the last 12 months, purchasing a net total of US$83k worth in shares. Recent Insider Transactions • Jun 18
Independent Director recently sold US$371k worth of stock On the 15th of June, James Crowley sold around 20k shares on-market at roughly US$18.57 per share. This transaction amounted to 27% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$422k. Insiders have been net sellers, collectively disposing of US$1.1m more than they bought in the last 12 months. Recent Insider Transactions • May 18
Independent Chairman recently sold US$418k worth of stock On the 15th of May, Thomas Cellitti sold around 21k shares on-market at roughly US$19.49 per share. This transaction amounted to 17% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Thomas has been a net seller over the last 12 months, reducing personal holdings by US$394k. Major Estimate Revision • May 16
Consensus EPS estimates increase by 14% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate increased from US$1.45 to US$1.66. Revenue forecast steady at US$384.9m. Net income forecast to grow 3.8% next year vs 15% growth forecast for Chemicals industry in the US. Consensus price target up from US$19.00 to US$22.00. Share price rose 3.3% to US$19.69 over the past week. Reported Earnings • May 10
First quarter 2023 earnings: EPS and revenues exceed analyst expectations First quarter 2023 results: EPS: US$0.69 (up from US$0.46 in 1Q 2022). Revenue: US$99.5m (up 9.8% from 1Q 2022). Net income: US$5.85m (up 55% from 1Q 2022). Profit margin: 5.9% (up from 4.2% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.1%. Earnings per share (EPS) also surpassed analyst estimates by 78%. Revenue is forecast to grow 1.8% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Mar 23
Independent Director recently sold US$151k worth of stock On the 16th of March, Ralph Hellmold sold around 9k shares on-market at roughly US$16.82 per share. This transaction amounted to 16% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$259k more than they bought in the last 12 months. Reported Earnings • Mar 15
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: US$1.44 (up from US$0.55 in FY 2021). Revenue: US$377.4m (up 23% from FY 2021). Net income: US$12.2m (up 175% from FY 2021). Profit margin: 3.2% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) also surpassed analyst estimates by 40%. Revenue is forecast to grow 2.6% p.a. on average during the next 2 years, compared to a 3.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has increased by 103% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improved over the past week After last week's 19% share price gain to US$12.78, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 12x in the Chemicals industry in the US. Total returns to shareholders of 318% over the past three years. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. Independent Director Sandy Kowaleski was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 09
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2022 results: EPS: US$0.16 (up from US$0.41 loss in 3Q 2021). Revenue: US$101.6m (up 25% from 3Q 2021). Net income: US$1.32m (up US$4.63m from 3Q 2021). Profit margin: 1.3% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 20%. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to stay flat during the next 2 years compared to a 2.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 47% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 10
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Second quarter 2022 results: EPS: US$0.26 (down from US$0.48 in 2Q 2021). Revenue: US$98.7m (up 23% from 2Q 2021). Net income: US$2.19m (down 43% from 2Q 2021). Profit margin: 2.2% (down from 4.8% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 19%. Earnings per share (EPS) also surpassed analyst estimates by 73%. Over the next year, revenue is forecast to stay flat compared to a 11% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 02
Investor sentiment improved over the past week After last week's 17% share price gain to US$11.74, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Chemicals industry in the US. Total returns to shareholders of 95% over the past three years. 